Mortally ill patients and excellent survival following cardiac transplantation.
Cardiac transplantation was resumed in 1980 at the University Health Center of Pittsburgh. Generally accepted criteria for selection of patients were used, one being the expectation that survival would not reach 6 months. All of the initial recipients were in New York Heart Association Functional Class IV, but many were ambulant. We soon saw patients who were more clearly terminally ill. They were characterized by a systolic arterial pressure of less than 80 mm Hg, a cardiac index of less than 2 L/min/m2, evidence of reduced blood flow as indicated by urine output of less than 20 ml per hour, impaired mental function, and signs of decreased peripheral perfusion. The initial success of cardiac transplantation in these patients prompted us to reconsider selection criteria to include them among less strikingly ill candidates and to develop a therapeutic protocol designed to maintain peripheral perfusion and adequate renal and hepatic function until transplantation could be accomplished. Actuarial survival at 30 months for the group of terminally ill patients was 75% compared with 67% for the less critically ill group. Actuarial survival at 30 months for the combined group of 77 patients was 67%. Twenty-nine of the 33 mortally ill patients were alive and active at the time of writing, January, 1985.
D000328:Adult; D006331:Heart Diseases / Q000401:mortality / Q000601:surgery*; D016027:Heart Transplantation; D006439:Hemodynamics; D006801:Humans; D007165:Immunosuppression Therapy; D008875:Middle Aged; D013997:Time Factors